28.68

0.74% -0.205

Harmony Biosciences Holdings Inc (HRMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRMY Giù? Forum Previsione

Precedente Chiudi:

$28.89

Aprire:

$28.75

Volume 24 ore:

7,930

Relative Volume:

0.01

Capitalizzazione di mercato:

$1.66B

Reddito:

$868.45M

Utile/perdita netta:

$158.69M

Rapporto P/E:

10.59

EPS:

2.7087

Flusso di cassa netto:

$328.64M

1 W Prestazione:

+3.48%

1M Prestazione:

+3.86%

6M Prestazione:

+8.78%

1 anno Prestazione:

-1.70%

Intervallo 1D:

$28.70

$28.76

Intervallo di 1 settimana:

$27.27

$29.50

Portata 52W:

$25.52

$40.87

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Nome

Harmony Biosciences Holdings Inc

Settore

Healthcare (1108)

Industria

Biotechnology (623)

Telefono

(484) 539-9800

Indirizzo

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Dipendente

293

Cinguettio

Prossima data di guadagno

2024-10-29

Ultimi documenti SEC

HRMY's Discussions on Twitter

Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRMY Harmony Biosciences Holdings Inc	28.71	1.67B	868.45M	158.69M	328.64M	2.7087
VRTX Vertex Pharmaceuticals Inc	436.05	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	750.33	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	800.13	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.19	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	310.52	34.37B	5.36B	287.73M	924.18M	2.5229

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-23	Downgrade	Deutsche Bank	Buy → Hold
2026-02-23	Downgrade	Truist	Buy → Hold
2026-02-11	Ripresa	UBS	Neutral
2025-07-21	Iniziato	Truist	Buy
2025-07-10	Ripresa	Goldman	Neutral
2025-06-02	Ripresa	Oppenheimer	Outperform
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-12-17	Iniziato	H.C. Wainwright	Buy
2024-10-10	Ripresa	Raymond James	Outperform
2024-09-10	Iniziato	UBS	Buy
2024-06-21	Iniziato	Citigroup	Buy
2024-01-02	Downgrade	BofA Securities	Neutral → Underperform
2023-09-25	Downgrade	Goldman	Neutral → Sell
2023-09-07	Iniziato	Berenberg	Buy
2023-04-20	Iniziato	BofA Securities	Neutral
2022-10-14	Aggiornamento	Janney	Neutral → Buy
2022-10-14	Aggiornamento	Jefferies	Hold → Buy
2022-08-03	Downgrade	Jefferies	Buy → Hold
2022-07-13	Downgrade	Goldman	Buy → Neutral
2022-07-07	Iniziato	Mizuho	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-04	Iniziato	Raymond James	Outperform
2021-09-23	Iniziato	Needham	Buy
2021-03-29	Aggiornamento	Goldman	Neutral → Buy
2020-09-14	Iniziato	Goldman	Neutral
2020-09-14	Iniziato	Jefferies	Buy
2020-09-14	Iniziato	Piper Sandler	Overweight

Mostra tutto

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

01:20 AM

Will Harmony’s New COO and Board Reboot Change Harmony Biosciences Holdings' (HRMY) Narrative? - simplywall.st

01:20 AM

01:18 AM

Analyst Upgrade: Can Harmony Biosciences Holdings Inc lead its sector in growthWeekly Earnings Recap & Weekly Market Pulse Updates - baoquankhu1.vn

01:18 AM

01:07 AM

Harmony Biosciences appoints COO, updates board membership - MSN

01:07 AM

Apr 11, 2026

Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial? - MSN

Apr 11, 2026

Apr 10, 2026

Harmony Biosciences to Present at Needham Healthcare Conference - MyChesCo

Apr 10, 2026

(HRMY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Apr 10, 2026

Can Harmony Biosciences Holdings Inc reach all time highs this yearRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Harmony Biosciences (HRMY) CCO RSUs Vest; 3,173 Shares Withheld for Taxes - Stock Titan

Apr 09, 2026

Apr 08, 2026